Biotechnology firm Amgen has recently implemented workforce reductions, impacting approximately 40 employees. These organizational changes are intended to better align operations with the company's strategic goals. The affected staff represent a small fraction of Amgen's global workforce. This move follows a period of challenges for the company, including regulatory scrutiny of its dr-g Tavneos and several pipeline setbacks. Amgen is actively working to address these issues and support its transitioning employees.
Thousand Oaks, California
https://www.fiercebiotech.com/biotech/amgen-sheds-around-40-staffers-struggles-pile-tavneos-pipeline